首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   246篇
  免费   3篇
  国内免费   7篇
耳鼻咽喉   1篇
儿科学   8篇
妇产科学   2篇
基础医学   5篇
临床医学   15篇
内科学   33篇
皮肤病学   7篇
神经病学   3篇
特种医学   6篇
外科学   6篇
综合类   51篇
预防医学   5篇
药学   104篇
中国医学   9篇
肿瘤学   1篇
  2023年   3篇
  2022年   4篇
  2021年   3篇
  2020年   1篇
  2019年   1篇
  2018年   5篇
  2017年   1篇
  2016年   2篇
  2014年   12篇
  2013年   16篇
  2012年   15篇
  2011年   11篇
  2010年   16篇
  2009年   11篇
  2008年   10篇
  2007年   9篇
  2006年   14篇
  2005年   14篇
  2004年   11篇
  2003年   15篇
  2002年   4篇
  2001年   6篇
  2000年   6篇
  1999年   1篇
  1998年   9篇
  1997年   8篇
  1996年   4篇
  1995年   3篇
  1994年   5篇
  1993年   2篇
  1992年   5篇
  1991年   7篇
  1990年   3篇
  1989年   2篇
  1988年   7篇
  1987年   4篇
  1986年   1篇
  1985年   1篇
  1984年   2篇
  1983年   2篇
排序方式: 共有256条查询结果,搜索用时 15 毫秒
1.
2.
目的:观察雷尼替丁与复方丹参联合治疗急性胰腺炎的疗效。方法:对确诊急性胰腺炎65例随机分成治疗组35例,对照组30例,分别用常规治疗,常规治疗加雷尼替丁与复方丹参静滴,连用4-7天,评价其疗效。结果:治疗组与对照组显效率分别为85.71%、43.3%,两组差异显著,P<0.05。结论:两药联合应用不仅可减轻本病的炎症病变,且可改善心肌细胞营养状况。  相似文献   
3.
Background: While dyspeptic patients in primary care often receive empirical treatment with antisecretory drugs, a substantial number suffer from motility disturbances which may be associated with their complaints. We aimed to compare the effectiveness of treatment with antisecretory treatment with a prokinetic agent in uninvestigated dyspepsia. Methods: 563 patients presenting dyspeptic complaints to the general practitioner with a low likelihood of organic (ulcer, reflux or malignant) disease, i.e. absence of alarm symptoms or a history of peptic ulcer disease or gastro-oesophageal reflux disease were included. They entered a randomized, double-blind trial of 4 weeks of ranitidine 150 mg bid compared with 4 weeks of cisapride 10 mg bid, with 3 months follow-up. Treatment failure was defined as no response to treatment or a relapse of symptoms within the follow-up period. Also studied were the effect on dyspepsia severity, response to treatment after 4 weeks, and time to relapse. Results: For all randomized patients, the incidence of overall treatment success after 3 months follow-up with antisecretory treatment was 107/271 (39.5%) and with a prokinetic agent 122/282 (43.3%); the risk difference was 3.8% (95% CI-4.4% to 12.0%); the difference in symptom severity score after 4 weeks of treatment was 0.3; 95% CI-0.4% to 1.0%. For patients responding to 4 weeks of treatment, relapsefree time was 86 days in the prokinetic group and 79 days in the acid suppression group (P = 0.005). Conclusions: Antisecretory and prokinetic therapies are equally effective in primary care patients with uninvestigated dyspeptic complaints, though relapse rates are lower in patients treated with prokinetic treatment.  相似文献   
4.

Background

Histamine regulates function of osteoclasts and osteoblasts, however data regarding the influence of histamine H2 receptors antagonists on bone tissue are ambiguous. Factors that influence growing skeleton may have an important impact on the peak bone mass and future risk of fractures. The aim of our study was the assessment of influence of ranitidine, on growing bones.

Methods

The experiment was carried out on young male Wistar rats divided into two groups receiving either ranitidine (10 mg/kg ip) or vehicle.

Results

A significant decrease in femoral BMD in ranitidine-treated rats (R) compared to vehicle-treated ones (C) was detected (0.262 ± 0.009 g/cm2vs. 0.271 ±0.007 g/cm2, p < 0.05). In group R we observed elevated serum C-terminated telopeptide of type I collagen (CTX) level with concomitantly lowered serum osteocalcin (OC) concentration comparing to control group (151.2 ± 27.2 pg/ml vs. 101.5 ± 55.6, p < 0.05 and 229.1 ± 50.0 pg/ml vs. 292.0 ± 52.9, p < 0.05, respectively). Serum concentration of inorganic phosphorus was lower in group R than in group C (134 ± 13 mmol/L vs. 157 ± 28 mmol/L, p < 0.05).

Conclusions

Long-term administration of ranitidine increases bone resorption and decreases bone formation in growing rats leading to decrease in BMD.  相似文献   
5.
李拓键  赵小兰 《中国药房》2014,(12):1094-1096
目的:比较含雷贝拉唑(RAZ)与枸橼酸铋雷尼替丁(RBC)的两种三联疗法治疗消化性溃疡的临床疗效。方法:将确诊为消化性溃疡的患者148例按随机数字表法均分为RAZ组和RBC组,分别给予RAZ/RBC+克拉霉素+甲硝唑的三联疗法治疗1周,之后两组患者均单服RAZ或RBC治疗3周,疗程共4周。治疗结束后比较两组患者的疗效、溃疡愈合率和幽门螺杆菌(Hp)根除情况,并观察治疗中的不良反应。结果:治疗结束后,RAZ组与RBC组患者的临床总有效率分别为88.7%、83.3%,Hp根除率分别为87.3%、93.1%,溃疡愈合率分别为85.9%、87.5%,两组比较差异均无统计学意义(P>0.05)。两组患者的不良反应均较轻,不影响治疗,可自行好转。结论:含RAZ与RBC的两种三联疗法治疗消化性溃疡的疗效相当,且安全性均较好。  相似文献   
6.
Signs of portal hypertension, history of upper gastro-intestinal tract bleeding episodes and outcome of the latter were recorded in 76 cirrhotic children evaluated for liver transplantation. Fifty-three (70%) had varices and 22 (29%) had experienced upper gastro-intestinal tract bleeding. Of these 22, 19 bled from varices and 3 from ulcers. Non bleeding ulcers were also found in five patients bleeding from varices. Iterative sclerotherapy controlled acute variceal bleeding in all but one patient in whom emergency transplantation was performed. Six of the eight patients with ulcers were successfully treated by the H2 histamine receptor antagonist ranitidine. We conclude that iterative sclerotherapy is efficient to control acute variceal bleeding and prevents recurrent bleeding in children with end-stage liver diseases awaiting liver replacement. Bleeding asymptomatic ulcers are frequent and respond to H2 histamine receptor antagonists.  相似文献   
7.
Bradycardia, an extremely rare side-effect of ranitidine therapy is described in a 4-day-old full-term male neonate, who was admitted because of massive gastro-intestinal bleeding. Two hours after the intravenous injection of 1 mg/kg body weight per day, ECG showed sinus bradycardia of 60 beats/min with normal axis and QRS complex.The bradycardia gradually resolved in the next 24 h.  相似文献   
8.
奥美拉唑治疗消化性溃疡的疗效及不良反应观察   总被引:1,自引:0,他引:1  
目的  探讨奥美拉唑治疗消化性溃疡的效果及不良反应的发生情况 ,以便指导临床用药。方法  对比分析奥美拉唑与雷尼替丁治疗消化性溃疡的疗效及不良反应。结果  奥美拉唑组的治疗效果明显优于雷尼替丁组 (P <0 .0 1) ;而不良反应明显低于雷尼替丁组 (P <0 .0 1)。结论 奥美拉唑是目前临床治疗消化性溃疡最安全有效的药物 ,值得推广应用  相似文献   
9.
AIM: Due of paucity of studies on stress ulcer prophylaxis in intracerebral hemorrhage (ICH), we have evaluated the usefulness of ranitidine and sucralfate in preventing gastric hemorrhage (GH) in patients with ICH. SUBJECTS AND METHODS: In a hospital-based randomized placebo-controlled study, patients with CT-proven ICH within 7 days of ictus were randomized into ranitidine 50 mg i.v. eight hourly, sucralfate 1 g six hourly and placebo groups. Patients were conservatively managed. Primary endpoint was occurrence of GH within 15 days of ictus and secondary endpoint 1-month mortality. RESULTS: The mean age of the patients was 57.2 (range 25-90) years and 40 were females. There were 45 patients in ranitidine, 49 in sucralfate and 47 in placebo group. Demographic, clinical and radiological features were not significantly different in 3 groups. GH occurred in 11 (23.4%) patients in placebo, 5 (11.1%) in ranitidine and 7 (14.3%) in sucralfate group, which was not significant. Only one female had GH. There were 13 (27.7%) deaths in placebo, 5 (11.1%) in ranitidine and 12 (24.5%) in sucralfate group. Pneumonia occurred in placebo group in 5 (10.6%), ranitidine in 2 (4.4%) and sucralfate in 5 (10.2%) patients, which was not significantly different. CONCLUSION: Ranitidine and sucralfate do not seem to significantly prevent GH or reduce 1-month mortality.  相似文献   
10.
Two Spectrophotometric procedures are presented for the determination of two commonly used H2-receptor antagonists, nizatidine (I) and ranitidine hydrochloride (II). The methods are based mainly on charge transfer complexation reaction of these drugs with either p-chloranilic acid (rho-CA) or 2, 3 dichloro-5, 6-dicyanoquinone (DDQ). The produced colored products are quantified spectrophotometrically at 515 and 467 nm in chloranilic acid and DDQ methods, respectively. The molar ratios for the reaction products and the optimum assay conditions were studied. The methods determine the cited drugs in concentration ranges of 20-200 and 20-160 microg/mL for nizatidine and ranges of 20-240 and 20-140 microg/mL for ranitidine with chloranilic acid and DDQ methods, respectively. A more detailed investigation of the complexes formed was made with respect to their composition, association constant, molar absorptivity and free energy change. The proposed procedures were successfully utilized in the determination of the drugs in pharmaceutical preparations. The standard addition method was applied by adding nizatidine and ranitidine to the previously analyzed tablets or capsules. The recovery of each drug was calculated by comparing the concentration obtained from the spiked mixtures with those of the pure drug. The results of analysis of commercial tablets and the recovery study (standard addition method) of the cited drugs suggested that there is no interference from any excipients, which are present in tablets or capsules. Statistical comparison of the results was performed with regard to accuracy and precision using student's t-test and F-ratio at 95% confidence level. There is no significant difference between the reported and proposed methods with regard to accuracy and precision.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号